| Literature DB >> 14630827 |
Catherine Thieblemont1, Valéry Nasser, Pascale Felman, Karen Leroy, Sophie Gazzo, Evelyne Callet-Bauchu, Béatrice Loriod, Samuel Granjeaud, Philippe Gaulard, Corinne Haioun, Alexandra Traverse-Glehen, Lucile Baseggio, François Bertucci, Daniel Birnbaum, Florence Magrangeas, Stéphane Minvielle, Hervé Avet-Loiseau, Gilles Salles, Bertrand Coiffier, Françoise Berger, Rémi Houlgatte.
Abstract
Non-germinal center small B-cell lymphomas represent a heterogeneous group of non-Hodgkin lymphomas, the most frequent histologic subtypes being small lymphocytic lymphoma (SLL), splenic marginal zone B-cell lymphoma (MZL), and mantle cell lymphoma (MCL). In order to identify genomic signatures specific for each disease, we analyzed 128 primary tumors using high-density microarrays. Several clusters of genes significantly discriminated the 3 histologic subtypes. Genes associated with cell adhesion, angiogenesis, and inhibition of apoptosis were up-regulated in SLL. Genes associated with intracellular signaling via the AKT1 pathway were up-regulated in splenic MZL. Genes associated with cell cycle control and multidrug resistance were up-regulated in MCL. Using 44 genes selected within the gene clusters discriminant for the 3 lymphoma subtypes, we generated a class prediction score that allowed us to classify the 3 entities in 96% of the cases, including borderline cases. Whereas specific transcriptional profiles easily distinguished all MZL samples, SLL samples, and most of the MCL samples into separate groups, few MCL cases exhibited MZL-type transcriptional profiles. This study demonstrates that SLL, splenic MZL, and MCL possess specific transcriptional profiles that may be relevant to the pathogenesis and the diagnosis of these histologic subtypes.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14630827 DOI: 10.1182/blood-2003-06-2160
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113